FCM
ELV icon

Fourpath Capital Management’s Elevance Health ELV Stock Holding History

Fourpath Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100
Closed -$52K – 401
2024
Q3 		$52K Buy
+100
New +$53.4K 0.01% 335

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Fourpath Capital Management's ELV Position: Q4 2024 in Review

Fourpath Capital Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 100 shares — an estimated $52K sold.

Fourpath Capital Management first reported a position in ELV in Q3 2024 and held it in 1 quarter. The position peaked at $52K in Q3 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Fourpath Capital Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Fourpath Capital Management sold 100 Elevance Health shares in Q4 2024, an estimated $52K.
  • Fourpath Capital Management first reported a position in Elevance Health in Q3 2024 and held it in 1 quarter.
  • Fourpath Capital Management's Elevance Health position peaked at $52K in Q3 2024.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Fourpath Capital Management's 13F filing for Q4 2024, filed 24 Jan 2025.